Background: Several species of Aspidosperma (Apocynaceae) are used as treatments for human diseases in the tropics. Aspidosperma olivaceum, which is used to treat fevers in some regions of Brazil, contains the monoterpenoid indole alkaloids (MIAs) aspidoscarpine, uleine, apparicine, and N-methyl-tetrahydrolivacine. Using bio-guided fractionation and cytotoxicity testing in a human hepatoma cell line, several plant fractions and compounds purified from the bark and leaves of the plant were characterized for specific therapeutic activity (and selectivity index, SI) in vitro against the blood forms of Plasmodium falciparum. Methods: The activity of A. olivaceum extracts, fractions, and isolated compounds was evaluated against chloroquine (CQ)-resistant P. falciparum blood parasites by in vitro testing with radiolabelled [
Background
Approximately half of the world's population is at risk for malaria; according to the World Health Organization (WHO), 219 million cases of the disease and an estimated 660,000 deaths were reported in 2010, mostly due to Plasmodium falciparum [1] . The recommended treatment for this life-threatening disease is artemisinin-based combination therapy (ACT), but the limited availability of ACT, decreased P. falciparum susceptibility to artemisinin derivatives [2, 3] , and the chloroquine (CQ)-resistance of Plasmodium vivax (including in populations in Brazil) [4] [5] [6] [7] indicate the need for new and inexpensive drugs for malaria control.
Plants of the Aspidosperma genus (Apocynaceae) are used as remedies to treat fever and several human diseases in Brazil [8] [9] [10] [11] . They grow in a large variety of habitats in the Americas, from arid fields to the inundated river margins of the Amazon Basin [11] . The main chemical constituents in these plants are monoterpene indole alkaloids (MIAs), which are believed to be primarily responsible for their pharmacological activities (analgesic, anti-inflammatory, bactericidal, central nervous system depressant) [12, 13] . Most importantly, several plant extracts and isolated molecules have been reported to have anti-malarial activity in experimental models [14] [15] [16] [17] . Several species are believed to be useful against human malaria in the endemic regions of the Amazon basin, among Aspidosperma sp and other plants rich in alkaloids [18] [19] [20] [21] . However, there have been no ethnopharmacological studies confirming their activities in human malaria in Brazil. Experimental testing with alkaloid-rich fractions of Aspidosperma nitidum has supported the belief that it is an anti-malarial remedy, based on its high levels of in vitro selectivity indexes in P. falciparum and its in vivo activity against malaria parasites in mice [21, 22] . The active molecule responsible for the antimalarial activity of A. nitidum has not yet been isolated.
Another species used against fever and malaria is Aspidosperma olivaceum [23] ; the present study examined A. olivaceum to determine its most promising anti-malarial compounds by focusing on MIAs that had been previously described in the plant's bark [8, 24] : aspidoscarpine (1), uleine (2), apparicine (3), N-methyl-tetrahydrolivacine (5), and olivacine (6) (Figure 1 ). These compounds were further studied using electron-impact mass spectrometry (MS/EI), electron spray ionization (ESI), and nuclear magnetic resonance (NMR). In parallel, cytotoxicity assays were used to analyse the in vitro activity of these compounds against P. falciparum to determine the compound(s) with the highest therapeutic activity.
Methods

General experimental procedures
The isolated compounds were characterized by 1 H, 13 C, Distortionless Enhancement by Polarisation Transfer (DEPT), Heteronuclear Multiple Quantum Coherence (HMQC), Heteronuclear Multiple-Bond Correlation (HMBC), and Correlation Spectroscopy (COSY) NMR using a Varian 300 MHz spectrophotometer. The spectra were recorded in CD 3 OD and CDCl 3 at 300.06 MHz for proton NMR and 75.45 MHz for 13 C NMR. EI/MS was used for mass spectrometry analysis using a mass spectrometer quadrupole (Thermo Electron Corporation, model DSQ II), with an electron impact energy of 70 eV. The conditions for the analysis were as follows: full-scan mode, positive ions, ion source temperature of 250°C, and mass range of 50-650 Da. The National Institute of Standards and Technology (NIST) Library was used with the direct insertion of the samples in the ion source (Direct Insertion Probe (DIP), Thermo Electron Corporation), with the following temperature program: initial temperature of 70°C, initial time of 20 sec, heating rate of 90°C/min, final temperature of 450°C, and hold time of 180 sec.
The positive mode was used to obtain spectra by electron spray ionisation-mass spectrometry (ESI-MS). The samples were introduced into the spectrometer using a syringe for the "offline" analysis, with probe electron-spray ionization and a triple quadrupole analyser (Micromass®, Quattro MicroTM API). A source temperature of 120°C, desolvation temperature of 350°C, and gas flow of 600 μL/min were used, with adjustments in the capillary voltages and cones specific for each sample. Each spectrum was produced by the accumulation of data for 1 minute [25] .
Plant material
Stem bark and leaves from A. olivaceum were collected at the campus of the Universidade Estadual de Maringá, Brazil, in May 2010, where the voucher specimen (HUEM 20500) is deposited; the registry number is 3641 at the IBAMA (Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renováveis).
Extraction and isolation
The plant materials (635 g of stem bark and 921 g of leaves) were dried in a circulating air oven, ground in a knife mill, and extracted by maceration in methanol for seven days. After the organic solvent was evaporated using a Rotavapor under reduced pressure at 40°C, the crude extracts were lyophilized and subjected to acid-base fractionation [26] . After complete acid-base partition, the stem bark (65.85 g) provided four alkaloid-rich fractions: acidic, neutral precipitate (NP), neutral, and basic. The fractions were lyophilized for further testing; the acidic fraction was also used to further isolate separate compounds as summarized in Figure 2 . Additionally, the crude leaf extract (65.96 g) was subjected to a simplified acidbase partition using the same solvents at the appropriate pHs [13, 26] ; three alkaloid-rich fractions were obtained (acidic fraction, basic residue, and basic fraction) and lyophilized for further testing. The acidic and basic fractions were also used to isolate compounds on preparative thinlayer chromatography (PTLC) plates (20 × 20 cm, with 1.0 mm thickness) of silica gel 60 F254 (Alugram®, Macherey-Nagel, Duren, Germany) activated for 2 hours at 100°C, and each spot was examined under UV light. In addition, the chromogenic reagent p-anisaldehyde was used as a developing agent to separate the compounds on TLC with silica gel 60 F254 plates (0.25 mm, Alugram), followed by heating at 105°C. The Dragendorff reagent was used for the initial detection of the compounds.
Compound (1) was isolated from the acidic leaf fraction using a mobile phase of chloroform, dichloromethane, and ethyl acetate (4.0:1.0:4.5 v/v, respectively) in an ammonia-saturated environment; compound (5) was isolated from the basic fraction using the same mobile phase with the addition of methanol (4.5:4.0:1.0:0.5 v/v, respectively). Compounds (1), (2) , and (3) were isolated from the stem bark, and the mobile consisted of chloroform, toluene, and methanol (10:2.0:0.5 v/v, respectively) in an ammonia-saturated environment. All of the compounds were dissolved in CHCl 3 :MeOH (1:1 v/v) and filtered through a sintered funnel, and the organic solvent was evaporated under reduced pressure. The samples were then subjected to NMR and MS analyses and lyophilized for biological testing.
In vitro testing against Plasmodium falciparum blood stages
The activities of the A. olivaceum extracts, fractions, and isolated compounds were evaluated against CQ-resistant P. falciparum (clone W2) blood parasites, which were cultured as previously described [27] , with modifications [28] . Immediately after synchronization in sorbitol [29] , the concentrated ring stages were incubated with the test compounds, which had been previously solubilised in 0.05% dimethylsulfoxide (DMSO) (v/v) using six serial concentrations (0.75-50 μg/mL). Each test was performed in triplicate; CQ was tested in parallel as an antimalarial control. The effects of the compounds against P. falciparum were measured using: (i) the [ 3 H]-hypoxanthine incorporation assay [30] and (ii) commercially available monoclonal antibodies specific for histidinerich protein (HRPII), a histidine-and alanine-rich parasite protein (MPFM ICLLAB-55A® and MPFG55P ICLLAB®, USA), as described previously [31] . The incorporation of spectrophotometer (SpectraMax340PC384, Molecular Devices). The half-maximal drug inhibitory response (IC 50 ) was estimated by curve fitting using software from OriginLab Corporation (Northampton, MA, USA). The results were compared with drug-free control wells, which were considered to represent 100% parasite viability.
Cytotoxicity testing in vitro
The cytotoxicity testing was performed in two cell lines: human hepatoma cells (HepG2) and normal kidney glomerular cells (BGM). Both of these cell lines were cultured in 75-cm 2 sterile flasks in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% heat-inactivated foetal calf serum and 40 mg/L gentamicin in a 5% CO 2 atmosphere at 37°C. When confluent, the cell monolayer was washed with culture medium, trypsinized, distributed in a flat-bottomed 96-well plate (5 × 10 3 cells/well), and incubated for 18 h at 37°C for cell adherence [32] . The compounds (20 μL) were diluted to various concentrations (1-1000 μg/mL) and incubated with the cells for 24 h in a 5% CO 2 atmosphere at 37°C. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL; 20 μL/well) was added to evaluate mitochondrial viability; after a further 3 h incubation, the supernatants were carefully removed, 100 μL of DMSO was added to each well, and the reactions were mixed to solubilize the formazan crystals. The optical density was determined at 570 nm and 630 nm to measure the signal and background, respectively (SpectraMax340PC384, Molecular Devices). The cell viability was expressed as a percentage of the control absorbance in the untreated cells after subtracting the appropriate background. The minimum lethal dose for 50% of the cells (MLD 50 ) was determined as described [33] , and the values were used to calculate the selectivity index (SI), which is the ratio between the cytotoxicity and the activity.
Anti-malarial tests against Plasmodium berghei in mice
The suppressive test of parasite growth in mice was performed as described [34] , with modifications [15] . Briefly, adult Swiss outbred mice (20 ± 2 g weigh) were inoculated by intraperitoneal injection with 1 × 10 5 P. berghei (ANKA strain)-infected red blood cells. The mice were maintained together for at least 2 h before, divided randomly into groups of six animals per cage, then treated with 100 or 200 mg/kg of each compound diluted in 3% DMSO in water (v/v), by daily gavage for three consecutive days. Two control groups (5 mice each) were used in parallel; one group was treated with CQ (20 mg/kg), and one group received the drug vehicle alone. Blood smears were prepared daily on postinfection days 5 through 10, methanol-fixed, stained with Giemsa, and examined microscopically in coded Table 1 In vitro activity of Aspidosperma olivaceum extracts and fractions against P. falciparum chloroquine-resistant blood parasites (W2 clone), cytotoxicity (MDL 50 ) to a human hepatoma cell line (HepG2), and selectivity index (SI), the ratio between the MDL 50 and IC 50
Compound* MDL 50 (μg/mL) IC 50 (μg/mL)** SI*** smears for parasitaemia counts. The percent inhibition of parasite growth was calculated relative to the untreated control group (considered 100% growth). For the Mann-Whitney test, the GraphPad Prism 5 program was used. Mortality was monitored daily.
The use of laboratory animals was approved by the Ethics Committee for Animal Use of the Oswaldo Cruz Foundation -Fiocruz (CEUA L-0046/08).
Results and discussion
The extracts of A. olivaceum were tested in vitro against CQ-resistant P. falciparum (W2 clone) blood parasites; most were active with IC 50 values below 10 μg/mL (Table 1 ). In the HRPII assay, the bark crude extract and its fractions (acidic and neutral precipitate) showed IC 50 values below 5.0 μg/mL; the leaf crude extract, the basic residue, and the acid fraction were also active. The purified compounds from the plant bark and leaves had IC 50 values between 3.2 and 4.4 μg/mL Two plant fractions were also tested in vivo, one was active ( Table 2) .
Most of the extracts displayed low toxicity, especially the crude leaf extract and its fractions, with SIs up to 126 (Table 1) . However, the neutral and basic fractions from the plant bark were toxic (SI below 10). Among the purified fractions, compound (1), aspidoscarpine, was the most promising (SI of 56), followed by compound (5) with a SI of 22; compounds (2) and (3) showed SI values of 18 and 14, respectively, and were considered moderately toxic. This is the first report regarding the isolation of two MIAs (1 and 5) from the leaves of A. olivaceum. The compounds aspidoscarpine, uleine, olivacine, and ellipticine had previously been characterized in other species of Aspidosperma. These compounds were also present in A. olivaceum and tested against P. falciparum in vitro in the present study, but some of the compounds were inactive or toxic ( Table 2 ). Novel molecules that are active in vitro have been identified in Aspidosperma parvifolium, A. olivaceum, Aspidosperma vargasii, and Aspidosperma ramiflorum. Extracts from A. vargasii and A. olivaceum have been tested and found to be active in mice infected with P. berghei [35] .
The potential of the active acid fraction to induce mutagenic and genotoxic effects in vitro was evaluated with Ames tests [36] , which were performed at the GenotoxRoyal Institute, Rio Grande do Sul, Brazil (contract GT00742). These tests utilized five strains of Salmonella typhimurium with different mutations and drug concentrations of up to 2,500 μg/plate in the absence and presence of the metabolizing rat liver fraction. None of the compounds exhibited mutagenic or genotoxic potential.
The acidic fraction and the basic residue from the leaves of A. olivaceum were evaluated for activity against P. berghei in mice with blood-induced malaria. The acidic fraction was active and reduced parasitaemia by as much as 79% at the 100 mg/kg dose; the 200 mg/kg dose reduced parasitaemia by as much as 58% (Table 2) . Only CQ, a control anti-malarial, caused 100% suppression of parasitaemia, and all of the mice survived until 30 days post infection, the last day of observation. Examining the time elapsed to reach 50% survival, half of the control non-treated malaria group survived 10 days of infection, and half of the mice treated with 200 mg/kg of the acid fraction survived approximately 21 days; half of the mice receiving 100 mg/kg survived 16 days (Figure 3) . Nevertheless, these differences were not statistically significant, and all of the animals died of malaria, except the animals in the CQ-treated group.
The chemical studies of A. olivaceum allowed us to isolate and characterize four MIAs using EI-MS, ESI-MS, and NMR: aspidoscarpine (1), uleine (2), apparicine (3) , and N-methyl-tetrahydrolivacine (5) (Figures 1, 2, 3, 4) . These compounds had been previously described in the bark of A. olivaceum [8] and in other Aspidosperma genera species [15, 16, 22] . They were isolated from A. olivaceum stem bark and leaves and identified by TLC fingerprints and ESI-MS; several of the predominant ion fragments found in the crude extract and fractions were found in the isolated compounds (1-3 and 5), suggesting that these compounds were present in the crude samples. + , which corresponded to aspidoscarpine (1), demethoxy-aspidospermine (4), uleine (2), apparicine (3), and olivacine (6), respectively. In the basic fraction, the ions were m/z 265 and 247 [M + H] + , which corresponded to apparicine (3) and olivacine (6), respectively. In the neutral precipitate, we detected the ions m/z 371, 265, and 247 [M + H] + , which corresponded to aspidoscarpine (1), apparicine (3), and olivacine (6), respectively, whereas ions with m/z 265, 247, and 355 [M + H] + , which corresponded to apparicine (3), olivacine (6) , and aspidospermine (7), respectively, were identified in the neutral fraction. The crude leaf extract contained peaks at m/z 371, 325, and 265 [M + H] + , which corresponded to aspidoscarpine (1), demethoxyaspidospermine (4) , and N-methyl-tetrahydrolivacine + . The NMR data were consistent with the literature [37] for aspidoscarpine (1), which was isolated from both the leaves and stem bark, in agreement with the MS and NMR data and literature [25] . Compound 2 was identified by EI/MS at 70 eV by . The NMR data indicated that this compound was N-methyl-tetrahydrolivacine (also known as guatambuine), which was consistent with the literature [25] .
Conclusion
Through a bio-monitoring approach and an evaluation of their anti-P. falciparum therapeutic activities, several extracts and fractions of A. olivaceum were isolated and found to be active; this report was the first successful isolation of MIA compounds from plant leaves. The MIA aspidoscarpine (1) was considered to be the most promising based on its high SI against P. falciparum and its low cytotoxicity in vitro. Other MIAs were isolated and were active in vitro, consistent with previous work on plant bark ( Table 2 ). The leaf acidic fraction was also active against malaria in mice with P. berghei, reducing parasitaemia and delaying malaria mortality. The present data confirmed the previously published results from Andrade-Neto et al. [15] using A. desmanthum, which also suggested that aspidoscarpine was the most active molecule in vitro against P. falciparum (IC 50 0.007). Together, these results indicate that aspidoscarpine may be an important anti-malarial lead that should be further analysed.
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